| Conversation
with geneticist Richard Myers
Q: Last year the final human genome sequence was announced. What
do we now know about the human genome from this international sequencing
effort?
A: People used to think that there were about 100,000
genes in the human genome. It turns out that there are only roughly 30,000
genes, but those genes may make millions of proteins because each gene
can be read in different ways. Of the 3 billion base pairs in the human
genome, only 5 percent looks like it is important. Of that 5 percent,
only half codes for proteins. The remaining 2.5 percent regulates when
and how those genes are turned on. Even identifying that 5 percent of
the genome turns out to be nontrivial, and that's just building the parts
list for the genome. Then we want to find out what those genes do. I think
it's going to take us 100 years to read this book of life.
Q: What about the remaining 95 percent of the genome?
A: We don't know. It could be that it's just important
to have a certain amount of space in the genome, or that DNA could play
a role in replication, cell division or the structure of the DNA. Some
of it may also play a role in regulating genes.
Q: How do you tell which parts of the genome are important?
A: The important parts are conserved in different species. If
it's a sequence that makes a critical protein, it will remain similar
even in distantly related animals. Less important regions of the genome
have a lot of variability. That's one reason why it's important to sequence
organisms that aren't closely related to humans. If you sequence only
humans and chimpanzees, which are our closest relatives, the entire sequence
will be quite similar and you can't learn which sequences are most important.
I'm on a government committee along with other professors at Stanford
including Arend Sidow and David Kingsley to decide which other organisms
should be sequenced. You want to look at the evolutionary tree and make
sure you have representative animals from all the branches, even if they
seem kind of obscure. There's a lot of interesting biology to be learned
from sequencing marsupials, for example.
Q: How has the human genome changed the way science is done?
A: We used to ask questions one gene at a time. Now you can think
about experiments on a large scale. We're not just looking at regulatory
sequences for one gene. We're looking at those sequences for all genes.
We're not just asking what role one gene plays in development. We're asking
how all genes interact. These types of experiments wouldn't be possible
without sequence data.
Q: What are some interesting questions in the field of genetics?
A: The hot new problem has actually been a problem since
scientists have been studying biology: Why does this cell do one thing
and this cell do another? The liver cell and nerve cell have exactly the
same DNA but why are they so different? A big part of answering that question
is to figure out what genes are turned on in the different cells and how
those genes are regulated. Even though this research has been going on
for a long time, we're now approaching the question in a different way.
We can now look at the expression and behaviors of all genes in each cell
type to learn how they are different.

|

Richard Myers, PhD, is the Stanford
W. Ascherman, MD, FACS, Professor in
Genetics and chair of the Department of Genetics. He is also director
of the Stanford Human Genome Center.
Med
school appoints Myers, Warnke to professorships (10/29/03)
Beyond
the beginning: plotting future genome research (4/16/03)
Genome
research at medical center boosted by $8 million national grant (10/15/03)
Stanford
Human Genome Center
|